Zhao Y - Search Results

1

The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.

Li P, Zheng X, Shou K, Niu Y, Jian C, Zhao Y, Yi W, Hu X, Yu A. Li P, et al. Among authors: zhao y. Am J Transl Res. 2016 Dec 15;8(12):5370-5385. eCollection 2016. Am J Transl Res. 2016. PMID: 28078009 Free PMC article.

2

Negative pressure wound therapy promotes muscle-derived stem cell osteogenic differentiation through MAPK pathway.

Liu H, Zheng X, Chen L, Jian C, Hu X, Zhao Y, Li Z, Yu A. Liu H, et al. Among authors: zhao y. J Cell Mol Med. 2018 Jan;22(1):511-520. doi: 10.1111/jcmm.13339. Epub 2017 Sep 25. J Cell Mol Med. 2018. PMID: 28944996 Free PMC article.

3

The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug.

Li DF, Yuan Y, Tu MJ, Hu X, Li YZ, Yi WR, Li PC, Zhao Y, Cheng Z, Yu AM, Jian C, Yu AX. Li DF, et al. Among authors: zhao y. Front Oncol. 2020 Feb 25;10:222. doi: 10.3389/fonc.2020.00222. eCollection 2020. Front Oncol. 2020. PMID: 32161722 Free PMC article.

4

Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model.

Yuan Y, Li D, Hu X, Li Y, Yi W, Li P, Zhao Y, Li Z, Yu A, Jian C, Yu A. Yuan Y, et al. Among authors: zhao y. Med Oncol. 2022 Apr 28;39(5):87. doi: 10.1007/s12032-022-01684-1. Med Oncol. 2022. PMID: 35478053

5

Circulating fibrocyte mobilization in negative pressure wound therapy.

Chen D, Zhao Y, Li Z, Shou K, Zheng X, Li P, Qi B, Yu A. Chen D, et al. Among authors: zhao y. J Cell Mol Med. 2017 Aug;21(8):1513-1522. doi: 10.1111/jcmm.13080. Epub 2017 Feb 17. J Cell Mol Med. 2017. PMID: 28211211 Free PMC article.

6

Vacuum-assisted closure increases ICAM-1, MIF, VEGF and collagen I expression in wound therapy.

Wang W, Pan Z, Hu X, Li Z, Zhao Y, Yu AX. Wang W, et al. Among authors: zhao y. Exp Ther Med. 2014 May;7(5):1221-1226. doi: 10.3892/etm.2014.1567. Epub 2014 Feb 20. Exp Ther Med. 2014. PMID: 24940415 Free PMC article.

7

Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest.

Zhao Y, Tu MJ, Wang WP, Qiu JX, Yu AX, Yu AM. Zhao Y, et al. Sci Rep. 2016 May 24;6:26611. doi: 10.1038/srep26611. Sci Rep. 2016. PMID: 27216562 Free PMC article.

8

Systematic Review and Meta-Analysis of Surgical Zipper Technique versus Intracutaneous Sutures for the Closing of Surgical Incision.

Chen D, Song J, Zhao Y, Zheng X, Yu A. Chen D, et al. Among authors: zhao y. PLoS One. 2016 Sep 9;11(9):e0162471. doi: 10.1371/journal.pone.0162471. eCollection 2016. PLoS One. 2016. PMID: 27611083 Free PMC article. Review.

9

Efficacy of thermosensitive chitosan/β-glycerophosphate hydrogel loaded with β-cyclodextrin-curcumin for the treatment of cutaneous wound infection in rats.

Zhao Y, Liu JG, Chen WM, Yu AX. Zhao Y, et al. Exp Ther Med. 2018 Feb;15(2):1304-1313. doi: 10.3892/etm.2017.5552. Epub 2017 Nov 23. Exp Ther Med. 2018. PMID: 29434717 Free PMC article.

10

Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.

Zhao Y, Tu MJ, Yu YF, Wang WP, Chen QX, Qiu JX, Yu AX, Yu AM. Zhao Y, et al. Biochem Pharmacol. 2015 Dec 15;98(4):602-13. doi: 10.1016/j.bcp.2015.10.015. Epub 2015 Oct 27. Biochem Pharmacol. 2015. PMID: 26518752 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87,696 results

Search Page

Filters